Schedule 13G ownership disclosure

KalVista Pharmaceuticals Inc

Security class unavailable · CUSIP: 483497103

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,000,000
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-006561
Form type
SC 13G
Filer
KalVista Pharmaceuticals, Inc.
CIK
CIK 1348911
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub